T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

X-linked acrogigantism syndrome: clinical profile and therapeutic responses

(2015) A. Beckers et al.   ENDOCRINE-RELATED CANCER

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients

(2015) Liliya Rostomyan et al.   ENDOCRINE-RELATED CANCER

Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences

(2015) I. Potorac et al.   ENDOCRINE-RELATED CANCER

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

(2015) Donato Iacovazzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A Structural and Functional Acromegaly Classification

(2015) Daniel Cuevas-Ramos et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly

(2014) Sauradeep Sarkar et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center

(2014) Ana Laura Espinosa-de-los-Monteros et al.   Pituitary

Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission

(2013) Robert M. Starke et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

(2012) Leandro Kasuki et al.   ENDOCRINE-RELATED CANCER

Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly

(2011) Ansgar Heck et al.   CLINICAL ENDOCRINOLOGY

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

(2011) Shlomo Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure

(2010) Manel Puig-Domingo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

(2009) Alberto Fernandez et al.   CLINICAL ENDOCRINOLOGY

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

(2009) Marie-Lise Jaffrain-Rea et al.   ENDOCRINE-RELATED CANCER

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

(2009) Shlomo Melmed et al.   Pituitary

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide

(2008) N. Karavitaki et al.   CLINICAL ENDOCRINOLOGY

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

(2008) A. Fusco et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy

(2008) Diego Ferone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM